{"id":206300,"date":"2026-08-17T11:37:21","date_gmt":"2026-08-17T06:07:21","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=206300"},"modified":"2026-08-17T11:37:21","modified_gmt":"2026-08-17T06:07:21","slug":"why-bharat-parenterals-ltd-share-price-near-52-week-high-2026-08-17","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-bharat-parenterals-ltd-share-price-near-52-week-high-2026-08-17\/","title":{"rendered":"Bharat Parenterals Ltd. (BPLPHARMA) Share Price Trades Within 2% of 52-Week High"},"content":{"rendered":"<style id=\"univest-disable-toc\">#ez-toc-container,.ez-toc-container,.lwptoc,.toc_container,.wp-block-rank-math-toc-block{display:none!important}<\/style>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\"><a href=\"https:\/\/univest.in\/stocks\/bplpharma\/bharat-parenterals-ltd-share-price-today\">Bharat Parenterals Ltd.<\/a> Share Price stood at Rs 1,360 at the event time, with the stock trading within 2% of its 52-week high and a market capitalisation of Rs 930.04 crore.<\/p>\n<p style=\"margin-top:0!important;\">Bharat Parenterals Ltd. Share Price was Rs 1,360 at 11:30:48 AM IST on 17 August 2026, when the Univest screener identified the stock as trading within 2% of its 52-week high. With a market capitalisation of Rs 930.04 crore, the move puts the counter on the radar for investors tracking price strength alongside valuation and business quality in the Healthcare space.<\/p>\n<p>The verified data confirms the proximity to the one-year peak, and that alone is meaningful because stocks near annual highs often attract fresh attention from market participants reviewing relative strength, valuation discipline and peer positioning. In this case, Bharat Parenterals Ltd. Share Price is drawing notice even as the company\u2019s reported P\/E stands at -60.85, while return ratios remain positive with ROE at 15.53% and ROCE at 20.24%.<\/p>\n<p>For readers following Bharat Parenterals Ltd. Share Price Today, the current setup matters less as a headline and more as a data point. Univest shows a stock close to its yearly high, operating in Pharmaceuticals &amp; Drugs, with a price-to-book ratio of 2.92 and book value per share of Rs 462.38. That combination makes Bharat Parenterals Ltd. Share Price relevant for both price-action watchers and fundamental screens.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Bharat_Parenterals_Ltd_Share_Price_Today_Within_2_of_52-Week_High\"><\/span><strong>Bharat Parenterals Ltd. Share Price Today: Within 2% of 52-Week High<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>LTP at 2% Qualification<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,360<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 930.04 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>52-Week High Position<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Trading within 2% of its 52-week high<\/td>\n<\/tr>\n<\/table>\n<p>Bharat Parenterals Ltd. (BPLPHARMA) traded at Rs 1,360. Reported volume was 397.<\/p>\n<p>Bharat Parenterals Ltd. Share Price Today was Rs 1,360 at the event qualification point captured by Univest, and the key fact established by the supplied data is that the stock was trading within 2% of its 52-week high. That places the counter close to an important reference zone that many investors monitor while assessing whether market interest is being sustained over a longer period rather than limited to a single session move.<\/p>\n<p>Because the screener event is based on proximity to the one-year high, Bharat Parenterals Ltd. Share Price naturally enters the conversation for traders and long-term market participants looking for stocks that are holding up near the upper end of their yearly range. Such positioning can matter because it often reflects continuing market attention, particularly when a stock with a Rs 930.04 crore market capitalisation remains near its recent highs in a closely tracked Healthcare segment.<\/p>\n<p>The available data does not establish a company-specific catalyst, but it does confirm why Bharat Parenterals Ltd. Share Price is appearing in searches around yearly highs and stock analysis. At Rs 1,360, the counter is in a zone where investors may begin comparing current valuation, profitability ratios and industry benchmarks more closely. That makes the next layer of analysis important: whether the fundamentals behind Bharat Parenterals Ltd. Share Price support the attention generated by this near-52-week-high setup.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Bharat_Parenterals_Ltd_BPLPHARMA_Fundamental_Analysis\"><\/span><strong>Bharat Parenterals Ltd. (BPLPHARMA) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 930.04 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-60.85x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.92x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">15.53%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">20.24%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs -22.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 462.38<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.07%<\/td>\n<\/tr>\n<\/table>\n<p>Bharat Parenterals Ltd. was valued at a P\/E ratio of -60.85x, a P\/B ratio of 2.92x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.<\/p>\n<p>Profitability and capital efficiency were represented by ROE of 15.53% and ROCE of 20.24%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.<\/p>\n<p>Per-share and shareholder-return metrics included EPS of Rs -22.35, book value per share of Rs 462.38, dividend yield of 0.07%. Dividend yield is a current or historical ratio and does not guarantee future distributions.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-60.85x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">19.13x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">30.65x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 361.02x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.92x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.75x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">15.53%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">9.87%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">20.24%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.57%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 930.04 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 137.36 crore<\/td>\n<\/tr>\n<\/table>\n<p>Bharat Parenterals Ltd. (BPLPHARMA) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Bharat Parenterals Ltd. (BPLPHARMA) has a P\/E ratio of -60.85x, which is below the benchmark median of 19.13x, a difference of -418.09%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Bharat Parenterals Ltd. (BPLPHARMA) has a ROE of 15.53%, which is above the benchmark median of 9.87%, a difference of +57.35%. Bharat Parenterals Ltd. (BPLPHARMA) has a ROCE of 20.24%, which is above the benchmark median of 12.57%, a difference of +61.02%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/kopran\/kopran-ltd-share-price-today\"><strong>Kopran Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">KOPRAN-BE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">918.15<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">36.75<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.71<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.4<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/wanbury\/wanbury-ltd-share-price-today\"><strong>Wanbury Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">WANBURY<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">915.43<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.3<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.64<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">87.61<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sudarshan\/sudarshan-pharma-industries-ltd-share-price-today\"><strong>Sudarshan Pharma Industries Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUDARSHAN<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">906.51<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">36.08<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.87<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.01<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/themismed\/themis-medicare-ltd-share-price-today\"><strong>Themis Medicare Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">THEMISMED<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">964.29<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">24.12<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.49<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">17.82<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.44<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sigachi\/sigachi-industries-ltd-share-price-today\"><strong>Sigachi Industries Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SIGACHI<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,040.5<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">41.04<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.96<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">38.11<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">37.83<\/td>\n<\/tr>\n<\/table>\n<p>Bharat Parenterals Ltd. (BPLPHARMA) has a P\/E ratio of -60.85x compared with the displayed peer median of 36.08x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 15.53% compares with a peer median of 17.82% across the companies shown in the table. ROCE stood at 20.24% versus the displayed peer median of 21.4%, providing a capital-efficiency comparison. Bharat Parenterals Ltd. (BPLPHARMA) has a market capitalisation of Rs 930.04 crore. Among the 5 peers shown, 2 have a larger market capitalisation.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Bharat_Parenterals_Ltd\"><\/span><strong>Why Investors Are Watching Bharat Parenterals Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Bharat Parenterals Ltd. Share Price<\/strong> was Rs 1,360 when the Univest screener flagged the stock as trading within 2% of its 52-week high.<\/li>\n<li>The company has a market capitalisation of Rs 930.04 crore, making it meaningful enough for investors to compare against listed industry peers.<\/li>\n<li>Fundamentals are mixed: P\/E is -60.85 and EPS is -22.35, while ROE at 15.53% and ROCE at 20.24% remain positive.<\/li>\n<li>P\/B at 2.92 is above the same-industry median of 1.75 and average of 2.31, suggesting the market is placing a relatively higher book-value multiple on the stock.<\/li>\n<li>Within the Pharmaceuticals &amp; Drugs peer set, Bharat Parenterals Ltd. Share Price shows competitive return ratios against several similarly sized companies.<\/li>\n<\/ul>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"About_Bharat_Parenterals_Ltd\"><\/span><strong>About Bharat Parenterals Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Bharat Parenterals Ltd. operates in the Healthcare sector and is classified under the Pharmaceuticals &amp; Drugs industry. That places the company in a segment where investors typically study earnings quality, return ratios, valuation multiples and peer comparisons closely, especially when a stock is trading near its yearly high.<\/p>\n<p>Based on the supplied classification data, Bharat Parenterals Ltd. is part of an industry universe of 138 listed companies used for same-industry benchmarking on Univest, while the broader Healthcare sector comparison spans 200 companies. This context matters because Bharat Parenterals Ltd. Share Price is not being assessed in isolation; it is being compared with other listed pharmaceutical businesses on metrics such as P\/E, P\/B, ROE, ROCE and market capitalisation.<\/p>\n<p>For investors tracking Bharat Parenterals Ltd. Stock News, the company currently stands out less because of descriptive business details in the supplied dataset and more because of its market positioning: a Rs 930.04 crore company in Pharmaceuticals &amp; Drugs, trading near its one-year high, with a negative P\/E but positive return ratios. That combination is what makes Bharat Parenterals Ltd. Share Price notable in the current screen.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Track_Bharat_Parenterals_Ltd_Share_Price_on_Univest\"><\/span><strong>Track Bharat Parenterals Ltd. Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/bplpharma\/bharat-parenterals-ltd-share-price-today\">Bharat Parenterals Ltd. (BPLPHARMA) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>Investors who want to follow Bharat Parenterals Ltd. Share Price can use Univest to track live price moves, 52-week levels, valuation ratios, profitability indicators, sector benchmarks, peer positioning and broader market insights in one place. For readers reviewing Bharat Parenterals Ltd. Share Price Today, that consolidated view is useful because the current setup combines a near-52-week-high price position with a fundamental profile that is not straightforward.<\/p>\n<p>Univest also helps users monitor how Bharat Parenterals Ltd. Share Price compares with industry medians, averages and similarly sized listed peers over time. That matters here because the stock\u2019s Rs 1,360 event price, negative P\/E and positive ROE and ROCE create a profile that benefits from regular cross-checking rather than a single-point reading.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Bharat_Parenterals_Ltd_Share_Price_today\"><\/span><strong>What is Bharat Parenterals Ltd. Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Bharat Parenterals Ltd. Share Price was Rs 1,360 at 11:30:48 AM IST on 17 August 2026, which is the exact event-time price captured when the Univest screener identified the stock near its yearly high.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Bharat_Parenterals_Ltd_Share_Price_in_focus_today\"><\/span><strong>Why is Bharat Parenterals Ltd. Share Price in focus today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Bharat Parenterals Ltd. Share Price is in focus because the stock was identified as trading within 2% of its 52-week high. The company also has a market capitalisation of Rs 930.04 crore in Pharmaceuticals &amp; Drugs.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Bharat_Parenterals_Ltd_Share_Price_near_its_52-week_high\"><\/span><strong>Is Bharat Parenterals Ltd. Share Price near its 52-week high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes, the supplied event confirms Bharat Parenterals Ltd. Share Price was trading within 2% of its 52-week high. That is the precise screen condition recorded by Univest at the event qualification time.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_the_valuation_data_show_for_Bharat_Parenterals_Ltd_Share_Price\"><\/span><strong>What does the valuation data show for Bharat Parenterals Ltd. Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The valuation picture is mixed. Bharat Parenterals Ltd. Share Price is associated with a P\/E of -60.85 and a P\/B of 2.92, indicating negative earnings but a book-value multiple above the industry median.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_profitable_is_Bharat_Parenterals_Ltd_based_on_the_supplied_ratios\"><\/span><strong>How profitable is Bharat Parenterals Ltd. based on the supplied ratios?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied profitability ratios show ROE of 15.53% and ROCE of 20.24%. Both are above the same-industry medians of 9.87% and 12.57%, respectively, which adds useful context to Bharat Parenterals Ltd. Share Price.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_EPS_book_value_and_dividend_yield_indicate_here\"><\/span><strong>What do EPS, book value and dividend yield indicate here?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> EPS is -22.35, which reflects negative earnings over the relevant period. Book value per share is Rs 462.38, while dividend yield is 0.07, showing a modest historical payout relative to Bharat Parenterals Ltd. Share Price.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Bharat_Parenterals_Ltd_compare_with_industry_benchmarks\"><\/span><strong>How does Bharat Parenterals Ltd. compare with industry benchmarks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Bharat Parenterals Ltd. is compared against 138 same-industry companies. Its P\/B of 2.92 is above the median 1.75, while ROE of 15.53% and ROCE of 20.24% both sit above industry medians.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Bharat_Parenterals_Ltd_compare_with_similar_listed_peers\"><\/span><strong>How does Bharat Parenterals Ltd. compare with similar listed peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Bharat Parenterals Ltd. has a market capitalisation of Rs 930.04 crore, close to peers like Kopran, Wanbury, Sudarshan Pharma and Themis Medicare. Its ROE and ROCE are competitive, but its P\/E remains negative versus peers\u2019 positive multiples.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bharat Parenterals Ltd. Share Price trades within 2% of its 52-week high at Rs 1,360. Market cap stands at Rs 930.04 crore.<\/p>\n","protected":false},"author":29,"featured_media":206299,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-206300","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["206299"],"rank_math_title":["Bharat Parenterals Ltd. Share Price: 52-Week High Focus"],"rank_math_description":["Bharat Parenterals Ltd. Share Price remains within 2% of its 52-week high. Check valuation, profitability and peer comparison in Healthcare."],"rank_math_focus_keyword":["Bharat Parenterals Ltd. Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/Bharat_Parenterals_Ltd_BPLPHARMA_Share_Price_Trades_Within_2_of_52_Week_High_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/206300","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=206300"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/206300\/revisions"}],"predecessor-version":[{"id":206301,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/206300\/revisions\/206301"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/206299"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=206300"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=206300"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=206300"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}